News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresenius Kabi AG Announces Launch of Oxaliplatin Injection, USP



8/9/2012 10:34:37 AM

SCHAUMBURG, Ill.--(BUSINESS WIRE) -- Fresenius Kabi today announced that is has launched Oxaliplatin Injection, USP. Oxaliplatin Injection, USP, is a platinum-based drug used in combination with infusional 5-fluorouracil/leucovorin, and indicated for adjuvant therapy of stage III colon cancer in patients who have undergone complete resection of the primary tumor as well as for the treatment of advanced colorectal cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES